Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 26, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.0K

Animal models in osteosarcoma.

Maria V Guijarro1, Steven C Ghivizzani1, C Parker Gibbs1

  • 1Department of Orthopaedics and Rehabilitation, University of Florida , Gainesville, FL , USA.

Frontiers in Oncology
|August 8, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

The bone & joint journal·2026
Same author

Osteoarthritis Gene Therapy: A 30-Year Journey From Concept to Clinical Trials.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2026
Same author

Pulmonary Metastasectomy Versus Stereotactic Beam Radiation Therapy for Sarcoma Pulmonary Metastasis: A Retrospective Cohort Study.

Cureus·2025
Same author

Integrated proteomic analysis identifies TYMS-dependent AMPK-mTOR signaling in pancreatic neuroendocrine tumors.

iScience·2025
Same author

Osteoarthritis gene therapy: Expanding the scope of genetic therapies.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

A phase 1 clinical trial shows safe, sustained, AAV-mediated expression of IL-1Ra in the human osteoarthritic knee joint.

Science translational medicine·2025
Same journal

Feasibility of uniportal thoracoscopic sublobar resection without chest tube drainage: a retrospective cohort study.

Frontiers in oncology·2026
Same journal

Real-world effectiveness and safety of carfilzomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma: a retrospective analysis from China.

Frontiers in oncology·2026
Same journal

Caregiver satisfaction with early integrated palliative care in oncology: secondary outcomes from the PALLiON cluster-RCT.

Frontiers in oncology·2026
Same journal

Intracranial mesenchymal tumor with FET::CREB fusion: a rare case report.

Frontiers in oncology·2026
Same journal

The multifaceted roles of mitochondria and their therapeutic transformation: a new perspective on triple-negative breast cancer treatment.

Frontiers in oncology·2026
Same journal

Trastuzumab emtansine versus trastuzumab plus pertuzumab for HER2-positive breast cancer with residual disease after neoadjuvant therapy: a real-world study.

Frontiers in oncology·2026
See all related articles

Osteosarcoma (OS) is a common bone cancer. While treatments improve survival for non-metastatic cases, metastatic OS remains challenging, necessitating better animal models for targeted therapies.

Area of Science:

  • Oncology
  • Genetics
  • Animal Models

Background:

  • Osteosarcoma (OS) is the most frequent primary bone tumor in children and adults.
  • Current treatments like chemotherapy and surgery improve survival for non-metastatic OS, but metastatic disease and relapse carry a poor prognosis.

Purpose of the Study:

  • To review genetically modified mouse models of osteosarcoma.
  • To highlight the need for improved animal models that better mimic human OS progression for developing new therapies.

Main Methods:

  • Review of genetically modified osteosarcoma mouse models.
  • Analysis of their utility in understanding molecular pathogenesis and disease progression.

Main Results:

  • Several genetically modified mouse models for osteosarcoma have been developed.
Keywords:
RBanimal modelsconditional mouse modelsgerm-line mouse modelsosteosarcomap53

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.3K
Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

1.6K

Related Experiment Videos

Last Updated: Apr 26, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.0K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.3K
Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

1.6K
  • These models offer insights into the molecular mechanisms of OS.

    • Conclusions:

    • Existing osteosarcoma mouse models are valuable but have limitations.
    • Development of more accurate models is crucial for advancing prognostic markers, diagnostic tools, and targeted therapies for both primary and metastatic osteosarcoma.